Cingulate Inc. (CING)
Data as of , from SEC Form 4 filings.
See up to 3 months of CING. The 7-day demo opens the 1M and 3M ranges and puts CING on your watchlist.
Start 7-day demoLatest CING insider trades
About Cingulate Inc. (CING)
Cingulate Inc. files with the SEC under CIK 0001862150 and is classified as pharmaceutical preparations. It is grouped with Health Care companies on this site.
CING Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Grant or award | 1 | 4,293 |
Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.
CING insider transactions (Form 4)
4634 Form 4 filings on record, the earliest from Oct 1, 2024, newest first. Filing history page 1 of 2.
| Traded | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Raul R. Silva - Officer | Grant or award | Stock Option (right to Buy) | 4,293 | $0.00 | - | |
| Shane J. Schaffer - Officer | Grant or award | Stock Option (right to Buy) | 197,650 | $0.00 | - | |
| Shane J. Schaffer - Officer | Grant or award | Stock Option (right to Buy) | 97,350 | $0.00 | - | |
| Bryan Wade Downey - Officer | Grant or award | Stock Option (right to Buy) | 67,000 | $0.00 | - | |
| Bryan Wade Downey - Officer | Grant or award | Stock Option (right to Buy) | 33,000 | $0.00 | - | |
| Bryan Jay Lawrence - Director | Grant or award | Stock Option (right to Buy) | 20,000 | $0.00 | - | |
| Matthew Brams - Officer | Grant or award | Stock Option (right to Buy) | 53,600 | $0.00 | - | |
| Matthew Brams - Officer | Grant or award | Stock Option (right to Buy) | 26,400 | $0.00 | - | |
| Thomas Jeffrey Hargroves - Director | Grant or award | Stock Option (right to Buy) | 20,000 | $0.00 | - | |
| Jennifer L. Callahan - Officer | Grant or award | Stock Option (right to Buy) | 40,200 | $0.00 | - | |
| Jennifer L. Callahan - Officer | Grant or award | Stock Option (right to Buy) | 19,800 | $0.00 | - | |
| Peter J. Werth - Director | Grant or award | Stock Option (right to Buy) | 20,000 | $0.00 | - | |
| Raul R. Silva - Officer | Grant or award | Stock Option (right to Buy) | 53,600 | $0.00 | - | |
| Raul R. Silva - Officer | Grant or award | Stock Option (right to Buy) | 26,400 | $0.00 | - | |
| Raul R. Silva - Officer | Grant or award | Stock Option (right to Buy) | 3,885 | $0.00 | - | |
| Thomas Jeffrey Hargroves - Director | Open-market purchase | Common Stock | 97,276 footnote F2 | $5.04 | $490K | |
| Thomas Jeffrey Hargroves - Director | Open-market purchase | Warrant to Purchase Common Stock | 77,821 footnote F2 | $0.10 | $8K | |
| Thomas Jeffrey Hargroves - Director | Grant or award | Stock Option (right to Buy) | 15,000 | $0.00 | - | |
| ||||||
| Raul R. Silva - Officer | Grant or award | Stock Option (right to Buy) | 3,422 | $0.00 | - | |
| Raul R. Silva - Officer | Grant or award | Common Stock | 4,526 | $0.00 | - | |
| Raul R. Silva - Officer | Tax withholding / forfeiture | Common Stock | 1,828 | $0.00 | - | |
| Shane J. Schaffer - Officer | Grant or award | Common Stock | 6,862 | $0.00 | - | |
| Shane J. Schaffer - Officer | Tax withholding / forfeiture | Common Stock | 2,959 | $0.00 | - | |
| Jennifer L. Callahan - Officer | Grant or award | Common Stock | 15,329 | $0.00 | - | |
| Jennifer L. Callahan - Officer | Tax withholding / forfeiture | Common Stock | 6,427 | $0.00 | - | |
| Nilay Dahyabhai Patel - Officer | Grant or award | Common Stock | 5,475 | $0.00 | - | |
| Nilay Dahyabhai Patel - Officer | Tax withholding / forfeiture | Common Stock | 2,086 | $0.00 | - | |
| Matthew Brams - Officer | Grant or award | Common Stock | 4,526 | $0.00 | - | |
| Matthew Brams - Officer | Tax withholding / forfeiture | Common Stock | 1,025 | $0.00 | - | |
| Peter J. Werth - Director | Open-market purchase | Common Stock | 19,455 | $5.04 | $98K | |
| Peter J. Werth - Director | Open-market purchase | Warrant to Purchase Common Stock | 15,564 | $0.10 | $2K | |
| Jennifer L. Callahan - Officer | Open-market purchase | Common Stock | 4,864 | $5.04 | $25K | |
| Jennifer L. Callahan - Officer | Open-market purchase | Warrant to Purchase Common Stock | 3,891 | $0.10 | $389 | |
| Shane J. Schaffer - Officer | Open-market purchase | Common Stock | 6,809 | $5.04 | $34K | |
| Shane J. Schaffer - Officer | Open-market purchase | Warrant to Purchase Common Stock | 5,447 | $0.10 | $545 | |
| Matthew Brams - Officer | Open-market purchase | Common Stock | 1,946 | $5.04 | $10K | |
| Matthew Brams - Officer | Open-market purchase | Warrant to Purchase Common Stock | 1,556 | $0.10 | $156 | |
| Raul R. Silva - Officer | Grant or award | Stock Option (right to Buy) | 6,625 | $0.00 | - | |
| Raul R. Silva - Officer | Grant or award | Stock Option (right to Buy) | 7,334 | $0.00 | - | |
| Bryan Wade Downey - Officer | Grant or award | Stock Option (right to Buy) | 30,000 | $0.00 | - | |
| Nilay Dahyabhai Patel - Officer | Grant or award | Stock Option (right to Buy) | 30,000 | $0.00 | - | |
| Raul R. Silva - Officer | Grant or award | Stock Option (right to Buy) | 51,500 | $0.00 | - | |
| Shane J. Schaffer - Officer | Grant or award | Stock Option (right to Buy) | 199,500 | $0.00 | - | |
| Laurie Myers - Officer | Grant or award | Stock Option (right to Buy) | 31,000 | $0.00 | - | |
| Jennifer L. Callahan - Officer | Grant or award | Stock Option (right to Buy) | 64,500 | $0.00 | - | |
| Matthew Brams - Officer | Grant or award | Stock Option (right to Buy) | 52,500 | $0.00 | - | |
CING insider trading FAQ
What is the latest insider trade for CING?
Cingulate Inc. (CING) had 1 insider filing in the last 90 days, with the most recent on 2 October 2026. The full record for CING runs to 34 Form 4 filings, the earliest from 1 October 2024. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying CING stock?
No insider purchases of CING were filed in the last 90 days. 10 purchases are on record for this company.
How many insiders are selling CING stock?
No insider sales of CING were filed in the last 90 days.
Where can I see CING SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects CING Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Raul R. Silva view on EDGAR
- - Shane J. Schaffer view on EDGAR
- - Bryan Wade Downey view on EDGAR
- - Bryan Jay Lawrence view on EDGAR
- - Matthew Brams view on EDGAR
- - Thomas Jeffrey Hargroves view on EDGAR
- - Jennifer L. Callahan view on EDGAR
- - Peter J. Werth view on EDGAR
- - Raul R. Silva view on EDGAR
Related companies with recent insider activity
Learn more
- What the Form 4 transaction codes mean
- Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
- Insider activity in Health Care
- Where CING's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow CING with a 7-day demo
- CING on your watchlist
- Every CING Form 4 filing on record
- Up to 3 months of CING price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive